
This study presents a novel AI-based model for automated heart failure adjudication in clinical trials, demonstrating 83% agreement with a clinical events committee. By reviewing only uncertain cases, the AI model can achieve 91% agreement while reducing workload by 84%. AI outcomes closely matched those from human adjudication, confirming its potential for efficient and accurate global clinical trials.
Like
Save
Share